Chemometric Analysis of UV-Visible Spectral Fingerprints for the Discrimination and Quantification of Clinical Anthracycline Drug Preparation Used in Oncology

Figure 5

Actual values vs. predicted values using PLS regression ((a) doxorubicin, (b) daunorubicin, and (c) epirubicin).

(a)

(b)

(c)